HHS· @HHSGov · X·· 28 天前精选AI 评分40
AI 导读
美国卫生与公众服务部(HHS)宣布,FDA推出新的罕见病框架计划(Rare Disease Framework Initiative),重新思考罕见病疗法的开发与审评方式,以更好反映各疾病特点、吸纳前沿科学,并将患者置于流程中心。HHS称罕见病需要超越一刀切的做法。
推荐理由
HHS与FDA推出罕见病框架计划,读者可了解监管层对罕见病药物开发与审评思路的调整方向。
正文
Rare diseases demand more than a one-size-fits-all approach.
@US_FDA’s new Rare Disease Framework Initiative is rethinking how treatments are developed and reviewed to better reflect each disease, embrace cutting-edge science, and put patients at the center of the process.
来源:HHS · x.com